Subretinal injection of the EIAV-ABCA4 vector (which contained the ABCA4 gene) in adults with Stargardt’s disease due to mutations in this gene demonstrated a lack of improvements in visual function, exacerbations of retinal pigment epithelium atrophy, and even chronic ocular hypertension [187]. This evidence concerns the gene ABCA4 and Stargardt disease.